BIOMAT Database Logo BIOMAT Database Logo

Macrolide prescriptions and erythromycin resistance of Streptococcus pyogenes. 2006

Carlo Gagliotti, and Lucia Nobilio, and Milena Milandri, and Maria Luisa Moro, and
Agenzia Sanitaria Regionale Emilia-Romagna, Bologna, Italy. cgagliotti@regione.emilia-romagna.it

This study shows a significant association between the number of macrolide prescriptions reimbursed by the Italian National Health Service and resistance of Streptococcus pyogenes to erythromycin in children from a region in northern Italy with high prevalence of erythromycin resistance. Recent prescription of a macrolide (especially azithromycin) is a predictor of erythromycin resistance, as well as a possible risk factor for resistance at a community level.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007558 Italy A country in southern Europe, a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. The capital is Rome. Sardinia
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D013222 State Medicine A system of medical care regulated, controlled and financed by the government, in which the government assumes responsibility for the health needs of the population. National Health Service, British,Socialized Medicine,British Health Service, National,British National Health Service,Medicine, Socialized,Medicine, State,Service, British National Health
D013290 Streptococcal Infections Infections with bacteria of the genus STREPTOCOCCUS. Group A Strep Infection,Group A Streptococcal Infection,Group A Streptococcal Infections,Group B Strep Infection,Group B Streptococcal Infection,Group B Streptococcal Infections,Infections, Streptococcal,Infection, Streptococcal,Streptococcal Infection

Related Publications

Carlo Gagliotti, and Lucia Nobilio, and Milena Milandri, and Maria Luisa Moro, and
Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates.
February 2000, The Journal of antimicrobial chemotherapy,
Carlo Gagliotti, and Lucia Nobilio, and Milena Milandri, and Maria Luisa Moro, and
Erythromycin resistance in Streptococcus pyogenes and macrolide consumption in a central Italian region.
August 2009, Infection,
Carlo Gagliotti, and Lucia Nobilio, and Milena Milandri, and Maria Luisa Moro, and
Relative erythromycin resistance in Streptococcus pyogenes.
May 1990, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
Carlo Gagliotti, and Lucia Nobilio, and Milena Milandri, and Maria Luisa Moro, and
Streptococcus pyogenes erythromycin resistance in Italy.
January 1999, Emerging infectious diseases,
Carlo Gagliotti, and Lucia Nobilio, and Milena Milandri, and Maria Luisa Moro, and
Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997).
December 2000, The Journal of antimicrobial chemotherapy,
Carlo Gagliotti, and Lucia Nobilio, and Milena Milandri, and Maria Luisa Moro, and
Erythromycin resistance of Streptococcus pyogenes in Madrid.
June 1998, The Pediatric infectious disease journal,
Carlo Gagliotti, and Lucia Nobilio, and Milena Milandri, and Maria Luisa Moro, and
Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001.
May 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Carlo Gagliotti, and Lucia Nobilio, and Milena Milandri, and Maria Luisa Moro, and
In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae: mechanisms of macrolide and tetracycline resistance.
January 2004, Antimicrobial agents and chemotherapy,
Carlo Gagliotti, and Lucia Nobilio, and Milena Milandri, and Maria Luisa Moro, and
Erythromycin resistance in Streptococcus pyogenes in Italy.
January 2000, Emerging infectious diseases,
Carlo Gagliotti, and Lucia Nobilio, and Milena Milandri, and Maria Luisa Moro, and
SmaI macrorestriction analysis of Italian isolates of erythromycin-resistant Streptococcus pyogenes and correlations with macrolide-resistance phenotypes.
January 2001, Microbial drug resistance (Larchmont, N.Y.),
Copied contents to your clipboard!